Chihiro Ando
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective Validation.
Journal: Respirology (Carlton, Vic.)
Published: September 06, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy.
Journal: International journal of clinical oncology
Published: April 03, 2025
The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004).
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 15, 2025
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer.
Journal: International journal of cancer
Published: July 07, 2023
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer.
Journal: Translational lung cancer research
Published: February 11, 2023
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study.
Journal: Cancers
Published: November 08, 2022
PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 19, 2022
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance.
Journal: Journal of cancer research and clinical oncology
Published: July 22, 2022
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer.
Journal: Cancer immunology research
Published: September 07, 2021
First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study.
Journal: Journal of cancer research and clinical oncology
Published: July 23, 2021
Last Updated: 09/26/2026